These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24709423)

  • 1. Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.
    Zhang S; Chung WC; Wu G; Egan SE; Xu K
    Neoplasia; 2014 Feb; 16(2):158-67. PubMed ID: 24709423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.
    Zheng X; Linke S; Dias JM; Zheng X; Gradin K; Wallis TP; Hamilton BR; Gustafsson M; Ruas JL; Wilkins S; Bilton RL; Brismar K; Whitelaw ML; Pereira T; Gorman JJ; Ericson J; Peet DJ; Lendahl U; Poellinger L
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3368-73. PubMed ID: 18299578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells.
    Kwon OJ; Valdez JM; Zhang L; Zhang B; Wei X; Su Q; Ittmann MM; Creighton CJ; Xin L
    Nat Commun; 2014 Jul; 5():4416. PubMed ID: 25048699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pivotal role of androgen signaling in Notch-responsive cells in prostate development, maturation, and regeneration.
    Aldahl J; Yu EJ; He Y; Hooker E; Wong M; Le V; Olson A; Lee DH; Kim WK; Murtaugh CL; Cunha GR; Sun Z
    Differentiation; 2019; 107():1-10. PubMed ID: 30927641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
    Li D; Zhan Y; Wang N; Tang F; Lee CJ; Bayshtok G; Moore AR; Wong EWP; Pachai MR; Xie Y; Sher J; Zhao JL; Khudoynazarova M; Gopalan A; Chan J; Khurana E; Shepherd P; Navone NM; Chi P; Chen Y
    Sci Adv; 2023 Apr; 9(14):eadc9446. PubMed ID: 37018402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signaling in prostate cancer: refining a therapeutic opportunity.
    Su Q; Xin L
    Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Notch Signaling and Cell-Differentiation Inhibitory Transcription Factors in Stable Chronic Obstructive Pulmonary Disease Patients.
    Di Stefano A; Gnemmi I; Rosani U; Maniscalco M; D'Anna SE; Brun P; Carriero V; Bertolini F; Balbi B; Ricciardolo FLM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.
    Packer JR; Hirst AM; Droop AP; Adamson R; Simms MS; Mann VM; Frame FM; O'Connell D; Maitland NJ
    FEBS Lett; 2020 Jan; 594(2):209-226. PubMed ID: 31468514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
    Del Castillo Velasco-Herrera M; van der Weyden L; Nsengimana J; Speak AO; Sjöberg MK; Bishop DT; Jönsson G; Newton-Bishop J; Adams DJ
    Mol Oncol; 2018 Feb; 12(2):239-255. PubMed ID: 29193607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in Notch ligand-receptor signaling interactions.
    Kuintzle R; Santat LA; Elowitz MB
    bioRxiv; 2024 Jul; ():. PubMed ID: 37662208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.
    Ku SY; Wang Y; Garcia MM; Yamada Y; Mizuno K; Long MD; Rosario S; Chinnam M; Al Assaad M; Puca L; Kim MJ; Bakht MK; Venkadakrishnan VB; Robinson BD; Acosta AM; Wadosky KM; Mosquera JM; Goodrich DW; Beltran H
    J Clin Invest; 2024 Jul; 134(17):. PubMed ID: 39024561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
    Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
    Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
    PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer.
    Belle VA; McDermott N; Meunier A; Marignol L
    Nat Rev Urol; 2014 Sep; 11(9):499-507. PubMed ID: 25134838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1.
    Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y
    Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.
    Chung WC; Zhang S; Challagundla L; Zhou Y; Xu K
    Neoplasia; 2017 Nov; 19(11):885-895. PubMed ID: 28938159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
    Li J; Hilimire TA; Liu Y; Wang L; Liang J; Gyorffy B; Sikirzhytski V; Ji H; Zhang L; Cheng C; Ding X; Kerr KR; Dowling CE; Chumanevich AA; Mack ZT; Schools GP; Lim CU; Ellis L; Zi X; Porter DC; Broude EV; McInnes C; Wilding G; Lilly MB; Roninson IB; Chen M
    J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38546787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
    Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
    BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming.
    Wang J; Chen S; Pan C; Li G; Tang Z
    Front Bioeng Biotechnol; 2022; 10():799152. PubMed ID: 35875485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.